Artia Global Partners LP Quant / Systematic

Location: Miami, FL

CIK: 0001937964 · Show all filings

Period: Q2 2026 (← Previous)

Filing Date: Aug 14, 2026

Total Value: $542M (100.0% shares, 0.0% debt)

Holdings (48)

ABVX ABIVAX SA 12.7%

Value $68.82M Shares 516,447 Est. Cost — Unrealized —

INSM INSMED INC 11.6%

Value $62.8M Shares 589,052 Est. Cost — Unrealized —

TRVI TREVI THERAPEUTICS INC 7.6%

Value $41.23M Shares 2,210,852 Est. Cost — Unrealized —

BTSG BRIGHTSPRING HEALTH SVCS INC 6.7%

Value $36.08M Shares 517,315 Est. Cost — Unrealized —

RVMD REVOLUTION MEDICINES INC 6.4%

Value $34.72M Shares 185,390 Est. Cost — Unrealized —

ARGX ARGENX SE 5.1%

Value $27.59M Shares 29,739 Est. Cost — Unrealized —

ALKS ALKERMES PLC 4.3%

Value $23.52M Shares 448,964 Est. Cost — Unrealized —

TVTX TRAVERE THERAPEUTICS INC 3.6%

Value $19.26M Shares 339,033 Est. Cost — Unrealized —

AZN ASTRAZENECA PLC 3.4%

Value $18.65M Shares 98,376 Est. Cost — Unrealized —

NAMS NEWAMSTERDAM PHARMA COMPANY 3.2%

Value $17.08M Shares 503,936 Est. Cost — Unrealized —

DNTH DIANTHUS THERAPEUTICS INC 2.9%

Value $15.89M Shares 162,990 Est. Cost — Unrealized —

XBI SPDR SERIES TRUST 2.9%

Value $15.82M Shares 100,000 Est. Cost — Unrealized —

DGX QUEST DIAGNOSTICS INC 2.5%

Value $13.8M Shares 65,122 Est. Cost — Unrealized —

IONS IONIS PHARMACEUTICALS INC 2.1%

Value $11.45M Shares 144,376 Est. Cost — Unrealized —

EYPT EYEPOINT INC 2.0%

Value $10.97M Shares 767,098 Est. Cost — Unrealized —

ALMS ALUMIS INC 1.4%

Value $7.838M Shares 278,546 Est. Cost — Unrealized —

VKTX VIKING THERAPEUTICS INC 1.3%

Value $7.05M Shares 180,731 Est. Cost — Unrealized —

CELC CELCUITY INC 1.1%

Value $6.206M Shares 59,316 Est. Cost — Unrealized —

CYTK CYTOKINETICS INC 1.1%

Value $6.023M Shares 70,700 Est. Cost — Unrealized —

MRK MERCK & CO INC 1.1%

Value $6.001M Shares 46,700 Est. Cost — Unrealized —

RAPP RAPPORT THERAPEUTICS INC 1.1%

Value $5.772M Shares 138,508 Est. Cost — Unrealized —

JNJ JOHNSON & JOHNSON 1.1%

Value $5.74M Shares 22,600 Est. Cost — Unrealized —

GH GUARDANT HEALTH INC 1.1%

Value $5.716M Shares 38,100 Est. Cost — Unrealized —

ABSI ABSCI CORPORATION 1.0%

Value $5.383M Shares 464,444 Est. Cost — Unrealized —

SRRK SCHOLAR ROCK HLDG CORP 1.0%

Value $5.296M Shares 96,285 Est. Cost — Unrealized —

SION SIONNA THERAPEUTICS INC 1.0%

Value $5.267M Shares 119,741 Est. Cost — Unrealized —

ASND ASCENDIS PHARMA A/S 0.9%

Value $4.732M Shares 17,740 Est. Cost — Unrealized —

ROIV ROIVANT SCIENCES LTD 0.8%

Value $4.594M Shares 129,800 Est. Cost — Unrealized —

PALI PALISADE BIO INC 0.8%

Value $4.164M Shares 1,992,367 Est. Cost — Unrealized —

EWTX EDGEWISE THERAPEUTICS INC 0.7%

Value $4.014M Shares 98,800 Est. Cost — Unrealized —

BIIB BIOGEN INC 0.7%

Value $3.983M Shares 18,437 Est. Cost — Unrealized —

XENE XENON PHARMACEUTICALS INC 0.7%

Value $3.923M Shares 65,000 Est. Cost — Unrealized —

BLTE BELITE BIO INC 0.7%

Value $3.848M Shares 24,989 Est. Cost — Unrealized —

MLYS MINERALYS THERAPEUTICS INC 0.7%

Value $3.718M Shares 137,800 Est. Cost — Unrealized —

PROK PROKIDNEY CORP 0.7%

Value $3.686M Shares 1,806,939 Est. Cost — Unrealized —

ELVN ENLIVEN THERAPEUTICS INC 0.7%

Value $3.659M Shares 72,100 Est. Cost — Unrealized —

ORKA ORUKA THERAPEUTICS INC 0.6%

Value $3.179M Shares 33,400 Est. Cost — Unrealized —

PTGX PROTAGONIST THERAPEUTICS INC 0.5%

Value $2.813M Shares 22,951 Est. Cost — Unrealized —

UTHR UNITED THERAPEUTICS CORP DEL 0.5%

Value $2.709M Shares 5,000 Est. Cost — Unrealized —

DRUG BRIGHT MINDS BIOSCIENCES INC 0.5%

Value $2.696M Shares 38,407 Est. Cost — Unrealized —

KNSA KINIKSA PHARMACEUTICALS INTL 0.3%

Value $1.867M Shares 29,200 Est. Cost — Unrealized —

CMPX COMPASS THERAPEUTICS INC 0.2%

Value $839K Shares 383,200 Est. Cost — Unrealized —

PRAX PRAXIS PRECISION MEDICINES I 0.2%

Value $837K Shares 2,500 Est. Cost — Unrealized —

KOD KODIAK SCIENCES INC 0.1%

Value $663K Shares 17,019 Est. Cost — Unrealized —

TENX TENAX THERAPEUTICS INC 0.1%

Value $612K Shares 42,080 Est. Cost — Unrealized —

NUVL NUVALENT INC 0.1%

Value $605K Shares 4,900 Est. Cost — Unrealized —

PEPG PEPGEN INC 0.1%

Value $370K Shares 205,324 Est. Cost — Unrealized —

SYRE SPYRE THERAPEUTICS INC 0.1%

Value $355K Shares 4,000 Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
ABVX	ABIVAX SA	516,447	$68.82M	12.7%	—	—	SPONSORED ADS	00370M103
INSM	INSMED INC	589,052	$62.8M	11.6%	—	—	COM PAR $.01	457669307
TRVI	TREVI THERAPEUTICS INC	2,210,852	$41.23M	7.6%	—	—	COM	89532M101
BTSG	BRIGHTSPRING HEALTH SVCS INC	517,315	$36.08M	6.7%	—	—	COM	10950A106
RVMD	REVOLUTION MEDICINES INC	185,390	$34.72M	6.4%	—	—	COM	76155X100
ARGX	ARGENX SE	29,739	$27.59M	5.1%	—	—	SPONSORED ADR	04016X101
ALKS	ALKERMES PLC	448,964	$23.52M	4.3%	—	—	SHS	G01767105
TVTX	TRAVERE THERAPEUTICS INC	339,033	$19.26M	3.6%	—	—	COM	89422G107
AZN	ASTRAZENECA PLC	98,376	$18.65M	3.4%	—	—	ORD	G0593M107
NAMS	NEWAMSTERDAM PHARMA COMPANY	503,936	$17.08M	3.2%	—	—	ORDINARY SHARES	N62509109
DNTH	DIANTHUS THERAPEUTICS INC	162,990	$15.89M	2.9%	—	—	COM	252828108
XBI	SPDR SERIES TRUST	100,000	$15.82M	2.9%	—	—	Put	78464A870
DGX	QUEST DIAGNOSTICS INC	65,122	$13.8M	2.5%	—	—	COM	74834L100
IONS	IONIS PHARMACEUTICALS INC	144,376	$11.45M	2.1%	—	—	COM	462222100
EYPT	EYEPOINT INC	767,098	$10.97M	2.0%	—	—	COM NEW	30233G209
ALMS	ALUMIS INC	278,546	$7.838M	1.4%	—	—	COM	022307102
VKTX	VIKING THERAPEUTICS INC	180,731	$7.05M	1.3%	—	—	COM	92686J106
CELC	CELCUITY INC	59,316	$6.206M	1.1%	—	—	COM	15102K100
CYTK	CYTOKINETICS INC	70,700	$6.023M	1.1%	—	—	COM NEW	23282W605
MRK	MERCK & CO INC	46,700	$6.001M	1.1%	—	—	COM	58933Y105
RAPP	RAPPORT THERAPEUTICS INC	138,508	$5.772M	1.1%	—	—	COM	75383L102
JNJ	JOHNSON & JOHNSON	22,600	$5.74M	1.1%	—	—	COM	478160104
GH	GUARDANT HEALTH INC	38,100	$5.716M	1.1%	—	—	COM	40131M109
ABSI	ABSCI CORPORATION	464,444	$5.383M	1.0%	—	—	COM	00091E109
SRRK	SCHOLAR ROCK HLDG CORP	96,285	$5.296M	1.0%	—	—	COM	80706P103
SION	SIONNA THERAPEUTICS INC	119,741	$5.267M	1.0%	—	—	COM	829401108
ASND	ASCENDIS PHARMA A/S	17,740	$4.732M	0.9%	—	—	ORD SHS	K08588103
ROIV	ROIVANT SCIENCES LTD	129,800	$4.594M	0.8%	—	—	SHS	G76279101
PALI	PALISADE BIO INC	1,992,367	$4.164M	0.8%	—	—	COM	696389402
EWTX	EDGEWISE THERAPEUTICS INC	98,800	$4.014M	0.7%	—	—	COM	28036F105
BIIB	BIOGEN INC	18,437	$3.983M	0.7%	—	—	COM	09062X103
XENE	XENON PHARMACEUTICALS INC	65,000	$3.923M	0.7%	—	—	COM	98420N105
BLTE	BELITE BIO INC	24,989	$3.848M	0.7%	—	—	SPONSORED ADS	07782B104
MLYS	MINERALYS THERAPEUTICS INC	137,800	$3.718M	0.7%	—	—	COM	603170101
PROK	PROKIDNEY CORP	1,806,939	$3.686M	0.7%	—	—	SHS CL A	74291D104
ELVN	ENLIVEN THERAPEUTICS INC	72,100	$3.659M	0.7%	—	—	COM	29337E102
ORKA	ORUKA THERAPEUTICS INC	33,400	$3.179M	0.6%	—	—	COM	687604108
PTGX	PROTAGONIST THERAPEUTICS INC	22,951	$2.813M	0.5%	—	—	COM	74366E102
UTHR	UNITED THERAPEUTICS CORP DEL	5,000	$2.709M	0.5%	—	—	COM	91307C102
DRUG	BRIGHT MINDS BIOSCIENCES INC	38,407	$2.696M	0.5%	—	—	COM NEW	10919W405
KNSA	KINIKSA PHARMACEUTICALS INTL	29,200	$1.867M	0.3%	—	—	ORD SHS CL A	G52694109
CMPX	COMPASS THERAPEUTICS INC	383,200	$839K	0.2%	—	—	COM	20454B104
PRAX	PRAXIS PRECISION MEDICINES I	2,500	$837K	0.2%	—	—	COM NEW	74006W207
KOD	KODIAK SCIENCES INC	17,019	$663K	0.1%	—	—	COM	50015M109
TENX	TENAX THERAPEUTICS INC	42,080	$612K	0.1%	—	—	COM NEW	88032L605
NUVL	NUVALENT INC	4,900	$605K	0.1%	—	—	COM	670703107
PEPG	PEPGEN INC	205,324	$370K	0.1%	—	—	COM	713317105
SYRE	SPYRE THERAPEUTICS INC	4,000	$355K	0.1%	—	—	COM NEW	00773J202